Related Experiment Video
Updated: Jul 17, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Assessing environmental modifiers of disease risk associated with rare mutations
1Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA 94305-5405, USA. alicesw@stanford.edu
Objective:
As disease-predisposing mutations are increasingly identified, there is growing need to assess the effects of lifestyle and environmental factors on disease risks in mutation carriers. Such assessment is difficult when the mutations are rare and evaluating them in large population samples is costly.
Methods:
This paper describes four study designs for evaluating the effects of environmental exposures in carriers of rare disease-predisposing mutations.
Results:
The strengths and weaknesses of the designs are assessed, and strategies for analyzing the data obtained from such designs are considered.
Conclusions:
When exposure effects in noncarriers are well-established and exposure is independent of carrier status in the population of disease-free controls, the case-only design provides a feasible and efficient method for inferring effects in carriers. When exposure effects in noncarriers are not well established, the most feasible design options are those that compare exposures in carrier cases to either untyped controls or to carrier controls. These two designs have complementary strengths and weaknesses; thus inferences are stronger when measures of association estimated using the two designs are consistent.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations
Cancer Prevention
Some...
Mutagenicity and Carcinogenicity
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
